In recent trading session, Hepion Pharmaceuticals Inc (NASDAQ:HEPA) saw 1.57 million shares changing hands at last check today with its beta currently measuring 1.59. Company’s
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) has a beta value of 1.59 and has seen 6.79 million shares traded in the last trading session. The HEPA stock
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) has a beta value of 1.59 and has seen 6.74 million shares traded in the last trading session. The company, currently
During the last session, Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s traded shares were 22.52 million, with the beta value of the company hitting 1.58. The 52-week high
During the last session, Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s traded shares were 24.44 million, with the beta value of the company hitting 1.58. The 52-week high
In the last trading session, 6.45 million shares of the Hepion Pharmaceuticals Inc (NASDAQ:HEPA) were traded, and its beta was 1.59. Most recently the company’s
Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s traded shares stood at 5.12 million during the last session, with the company’s beta value hitting 1.59. At the close of
Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s traded shares stood at 4.36 million during the last session, with the company’s beta value hitting 1.59. At the close of
In the last trading session, 8.46 million Hepion Pharmaceuticals Inc (NASDAQ:HEPA) shares changed hands as the company’s beta touched 1.65. With the company’s per share
In the last trading session, 7.62 million Hepion Pharmaceuticals Inc (NASDAQ:HEPA) shares changed hands as the company’s beta touched 1.63. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
